UniProt ID | COX41_HUMAN | |
---|---|---|
UniProt AC | P13073 | |
Protein Name | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | |
Gene Name | COX4I1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 169 | |
Subcellular Localization | Mitochondrion inner membrane. | |
Protein Description | This protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.. | |
Protein Sequence | MLATRVFSLVGKRAISTSVCVRAHESVVKSEDFSLPAYMDRRDHPLPEVAHVKHLSASQKALKEKEKASWSSLSMDEKVELYRIKFKESFAEMNRGSNEWKTVVGGAMFFIGFTALVIMWQKHYVYGPLPQSFDKEWVAKQTKRMLDMKVNPIQGLASKWDYEKNEWKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Methylation | RVFSLVGKRAISTSV HHHHHHCCCCCCCHH | 31.04 | - | |
12 | Acetylation | RVFSLVGKRAISTSV HHHHHHCCCCCCCHH | 31.04 | 25953088 | |
26 | Phosphorylation | VCVRAHESVVKSEDF HHHHHCCHHCCCCCC | 23.49 | 21406692 | |
29 | Ubiquitination | RAHESVVKSEDFSLP HHCCHHCCCCCCCCC | 46.07 | 21890473 | |
29 | Acetylation | RAHESVVKSEDFSLP HHCCHHCCCCCCCCC | 46.07 | 25038526 | |
29 | Succinylation | RAHESVVKSEDFSLP HHCCHHCCCCCCCCC | 46.07 | 21890473 | |
29 | Succinylation | RAHESVVKSEDFSLP HHCCHHCCCCCCCCC | 46.07 | - | |
29 | Ubiquitination | RAHESVVKSEDFSLP HHCCHHCCCCCCCCC | 46.07 | 21890473 | |
30 | Phosphorylation | AHESVVKSEDFSLPA HCCHHCCCCCCCCCC | 30.68 | 25159151 | |
34 | Phosphorylation | VVKSEDFSLPAYMDR HCCCCCCCCCCCCCC | 45.85 | 23312004 | |
38 | Nitration | EDFSLPAYMDRRDHP CCCCCCCCCCCCCCC | 9.52 | - | |
38 | Phosphorylation | EDFSLPAYMDRRDHP CCCCCCCCCCCCCCC | 9.52 | - | |
53 | Ubiquitination | LPEVAHVKHLSASQK CCCCHHHHHHCHHHH | 29.03 | 21890473 | |
53 | Malonylation | LPEVAHVKHLSASQK CCCCHHHHHHCHHHH | 29.03 | 26320211 | |
53 | Ubiquitination | LPEVAHVKHLSASQK CCCCHHHHHHCHHHH | 29.03 | 21890473 | |
53 | Acetylation | LPEVAHVKHLSASQK CCCCHHHHHHCHHHH | 29.03 | 19608861 | |
53 | 2-Hydroxyisobutyrylation | LPEVAHVKHLSASQK CCCCHHHHHHCHHHH | 29.03 | - | |
56 | Phosphorylation | VAHVKHLSASQKALK CHHHHHHCHHHHHHH | 26.12 | 24719451 | |
58 | Phosphorylation | HVKHLSASQKALKEK HHHHHCHHHHHHHHH | 28.92 | 25849741 | |
60 | Succinylation | KHLSASQKALKEKEK HHHCHHHHHHHHHHH | 53.87 | - | |
60 | Succinylation | KHLSASQKALKEKEK HHHCHHHHHHHHHHH | 53.87 | 27452117 | |
60 | Ubiquitination | KHLSASQKALKEKEK HHHCHHHHHHHHHHH | 53.87 | 19608861 | |
60 | Malonylation | KHLSASQKALKEKEK HHHCHHHHHHHHHHH | 53.87 | 26320211 | |
60 | Acetylation | KHLSASQKALKEKEK HHHCHHHHHHHHHHH | 53.87 | 19608861 | |
63 | Methylation | SASQKALKEKEKASW CHHHHHHHHHHHCCH | 72.15 | - | |
67 | Succinylation | KALKEKEKASWSSLS HHHHHHHHCCHHHCC | 59.81 | 23954790 | |
67 | Malonylation | KALKEKEKASWSSLS HHHHHHHHCCHHHCC | 59.81 | 26320211 | |
67 | Acetylation | KALKEKEKASWSSLS HHHHHHHHCCHHHCC | 59.81 | 25953088 | |
67 | Ubiquitination | KALKEKEKASWSSLS HHHHHHHHCCHHHCC | 59.81 | - | |
69 | Phosphorylation | LKEKEKASWSSLSMD HHHHHHCCHHHCCHH | 38.26 | 21406692 | |
71 | Phosphorylation | EKEKASWSSLSMDEK HHHHCCHHHCCHHHC | 20.93 | 21406692 | |
72 | Phosphorylation | KEKASWSSLSMDEKV HHHCCHHHCCHHHCH | 20.43 | 21406692 | |
74 | Phosphorylation | KASWSSLSMDEKVEL HCCHHHCCHHHCHHE | 26.57 | 21406692 | |
87 | 2-Hydroxyisobutyrylation | ELYRIKFKESFAEMN HEEEEEEHHHHHHHC | 47.66 | - | |
87 | Acetylation | ELYRIKFKESFAEMN HEEEEEEHHHHHHHC | 47.66 | 23954790 | |
87 | Ubiquitination | ELYRIKFKESFAEMN HEEEEEEHHHHHHHC | 47.66 | - | |
87 | Succinylation | ELYRIKFKESFAEMN HEEEEEEHHHHHHHC | 47.66 | 23954790 | |
87 | Malonylation | ELYRIKFKESFAEMN HEEEEEEHHHHHHHC | 47.66 | 26320211 | |
89 | Phosphorylation | YRIKFKESFAEMNRG EEEEEHHHHHHHCCC | 30.28 | 20068231 | |
93 | Sulfoxidation | FKESFAEMNRGSNEW EHHHHHHHCCCCCHH | 3.57 | 21406390 | |
124 | Phosphorylation | VIMWQKHYVYGPLPQ HHHHHHHCCCCCCCC | 11.47 | - | |
126 | Phosphorylation | MWQKHYVYGPLPQSF HHHHHCCCCCCCCCC | 13.08 | 28064214 | |
132 | Phosphorylation | VYGPLPQSFDKEWVA CCCCCCCCCCHHHHH | 33.21 | 25159151 | |
135 | 2-Hydroxyisobutyrylation | PLPQSFDKEWVAKQT CCCCCCCHHHHHHHH | 52.01 | - | |
135 | Acetylation | PLPQSFDKEWVAKQT CCCCCCCHHHHHHHH | 52.01 | 25825284 | |
135 | Ubiquitination | PLPQSFDKEWVAKQT CCCCCCCHHHHHHHH | 52.01 | 21890473 | |
135 | Ubiquitination | PLPQSFDKEWVAKQT CCCCCCCHHHHHHHH | 52.01 | 21890473 | |
140 | Ubiquitination | FDKEWVAKQTKRMLD CCHHHHHHHHHHHHH | 49.21 | - | |
149 | Ubiquitination | TKRMLDMKVNPIQGL HHHHHHCCCCCCHHH | 38.23 | 21890473 | |
149 | 2-Hydroxyisobutyrylation | TKRMLDMKVNPIQGL HHHHHHCCCCCCHHH | 38.23 | - | |
149 | Ubiquitination | TKRMLDMKVNPIQGL HHHHHHCCCCCCHHH | 38.23 | 21906983 | |
158 | Phosphorylation | NPIQGLASKWDYEKN CCCHHHHHHHCHHCC | 39.04 | 20068231 | |
159 | Ubiquitination | PIQGLASKWDYEKNE CCHHHHHHHCHHCCC | 38.18 | 21890473 | |
159 | Acetylation | PIQGLASKWDYEKNE CCHHHHHHHCHHCCC | 38.18 | 27452117 | |
159 | 2-Hydroxyisobutyrylation | PIQGLASKWDYEKNE CCHHHHHHHCHHCCC | 38.18 | - | |
159 | Ubiquitination | PIQGLASKWDYEKNE CCHHHHHHHCHHCCC | 38.18 | 21890473 | |
164 | Ubiquitination | ASKWDYEKNEWKK-- HHHHCHHCCCCCC-- | 54.67 | 21906983 | |
164 | Acetylation | ASKWDYEKNEWKK-- HHHHCHHCCCCCC-- | 54.67 | 25825284 | |
164 | Ubiquitination | ASKWDYEKNEWKK-- HHHHCHHCCCCCC-- | 54.67 | 21890473 | |
168 | Acetylation | DYEKNEWKK------ CHHCCCCCC------ | 42.29 | 11794739 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of COX41_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of COX41_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COX41_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
SDCB1_HUMAN | SDCBP | physical | 25416956 | |
ECHM_HUMAN | ECHS1 | physical | 26186194 | |
ODB2_HUMAN | DBT | physical | 26186194 | |
FMC1_HUMAN | C7orf55 | physical | 26186194 | |
GCSP_HUMAN | GLDC | physical | 26186194 | |
ALDOA_HUMAN | ALDOA | physical | 26344197 | |
BAP29_HUMAN | BCAP29 | physical | 26344197 | |
BAP31_HUMAN | BCAP31 | physical | 26344197 | |
CISD2_HUMAN | CISD2 | physical | 26344197 | |
COX5A_HUMAN | COX5A | physical | 26344197 | |
OST48_HUMAN | DDOST | physical | 26344197 | |
NDUA2_HUMAN | NDUFA2 | physical | 26344197 | |
NDUS4_HUMAN | NDUFS4 | physical | 26344197 | |
PHB_HUMAN | PHB | physical | 26344197 | |
SSRG_HUMAN | SSR3 | physical | 26344197 | |
SSRD_HUMAN | SSR4 | physical | 26344197 | |
TPM1_HUMAN | TPM1 | physical | 26344197 | |
TPM2_HUMAN | TPM2 | physical | 26344197 | |
TPM3_HUMAN | TPM3 | physical | 26344197 | |
TPM4_HUMAN | TPM4 | physical | 26344197 | |
QCR7_HUMAN | UQCRB | physical | 26344197 | |
VDAC1_HUMAN | VDAC1 | physical | 26344197 | |
VDAC2_HUMAN | VDAC2 | physical | 26344197 | |
FMC1_HUMAN | C7orf55 | physical | 28514442 | |
ODB2_HUMAN | DBT | physical | 28514442 | |
COR1A_HUMAN | CORO1A | physical | 28514442 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB02659 | Cholic Acid |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-53 AND LYS-60, AND MASSSPECTROMETRY. |